Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $41,850 $41,850
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 350,000 379,615
Total Sell Value $0 $0 $5,692,673 $6,289,886
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 227
  Page 4 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-11-26 4 AS $35.49 $453,110 I/I (12,674) 3,029,191     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-11-26 4 AS $35.49 $758,282 I/I (21,210) 4,970,716     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-11-24 4 AS $35.20 $2,206,510 I/I (60,808) 4,991,926     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-11-24 4 AS $35.20 $1,318,543 I/I (36,337) 3,041,865     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-11-23 4 AS $36.21 $1,212,340 I/I (33,476) 5,052,734     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-11-23 4 AS $36.21 $724,449 I/I (20,004) 3,078,202     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-11-23 4 AS $36.08 $523,160 D/D (14,500) 78,200     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-11-22 4 AS $37.16 $1,325,817 I/I (35,333) 5,086,210     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-11-22 4 AS $37.16 $792,271 I/I (21,114) 3,098,206     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-11-22 4 OE $12.45 $202,474 D/D 16,263 92,700     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2021-11-18 4 AS $34.50 $966,000 D/D (28,000) 0     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2021-11-18 4 OE $4.30 $120,400 D/D 28,000 28,000     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-11-17 4 AS $0.00 $0 I/I (15,671) 5,121,543     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-11-17 4 AS $0.00 $0 I/I (15,671) 3,119,320     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-11-03 4 AS $28.89 $175,777 D/D (6,085) 76,437     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-11-02 4 AS $28.42 $408,920 D/D (14,391) 82,522     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-11-01 4 AS $28.00 $2,268 D/D (81) 96,913     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-10-21 4 AS $28.00 $5,488 D/D (196) 96,994     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-10-19 4 AS $28.00 $5,628 D/D (201) 97,190     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-18 4 AS $27.14 $167,372 I/I (6,167) 3,134,991     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-18 4 AS $27.14 $167,372 I/I (6,167) 3,134,991     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-18 4 AS $27.14 $280,085 I/I (10,320) 5,137,214     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-10-15 4 AS $28.01 $45,796 D/D (1,635) 97,391     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-15 4 AS $27.53 $301,937 I/I (10,932) 3,141,158     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-15 4 AS $27.53 $301,937 I/I (10,932) 3,141,158     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us